Young Li
Stock Analyst at Jefferies
(0.54)
# 4,453
Out of 5,182 analysts
8
Total ratings
40%
Success rate
-13.65%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Buy | $28 → $22 | $27.29 | -21.22% | 1 | Jan 28, 2026 | |
| TMDX TransMedics Group | Initiates: Buy | $145 | $97.08 | +49.36% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $7.38 | +21.95% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $61.52 | +86.93% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.81 | -30.94% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $23.34 | +157.07% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $14.58 | +215.50% | 1 | Jul 16, 2021 |
STAAR Surgical Company
Jan 28, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $27.29
Upside: -21.22%
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $97.08
Upside: +49.36%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $7.38
Upside: +21.95%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $61.52
Upside: +86.93%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.81
Upside: -30.94%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $23.34
Upside: +157.07%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $14.58
Upside: +215.50%